Raisa Levin
Biographic Data
| ID | 5543510 |
|---|---|
| NAME | Raisa Levin |
| GIVEN NAMES | Raisa |
| FAMILY NAME | Levin |
| SIGNATURE | LEVIN R |
| AFFILIATIONS | Brigham and Women's Hospital |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1998 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Health Care Spending After Initiating Sacubitril-Valsartan vs Renin-Angiotensin System Blockers for Heart Failure Treatment
This cohort study found that Medicare beneficiaries initiating sacubitril-valsartan to treat HFrEF had similar total health care spending as those initiating ACE-I/ARBs; higher prescription drug spending was offset by lower inpatient and outpatient spending. However, sacubitril-valsartan use was associated with higher patient out-of-pocket costs, which may exacerbate health disparities and limit access and affordability
Patient Noncompliance in the Managed Care Setting: The Case of Medical Therapy for Glaucoma
OBJECTIVES: The authors identify demographic and clinical characteristics associated with noncompliance in patients beginning medical therapy for the treatment of glaucoma in a managed care setting. METHODS: The authors describe a retrospective cohort study in a group-model health maintenance organization in Massachusetts. Patients were members of the health maintenance organization who were newly initiated on topical drug therapy to treat open-a…
No prominent works on this page.
Patient Noncompliance in the Managed Care Setting: The Case of Medical Therapy for Glaucoma
OBJECTIVES: The authors identify demographic and clinical characteristics associated with noncompliance in patients beginning medical therapy for the treatment of glaucoma in a managed care setting. METHODS: The authors describe a retrospective cohort study in a group-model health maintenance organization in Massachusetts. Patients were members of the health maintenance organization who were newly initiated on topical drug therapy to treat open-a…
Health Care Spending After Initiating Sacubitril-Valsartan vs Renin-Angiotensin System Blockers for Heart Failure Treatment
This cohort study found that Medicare beneficiaries initiating sacubitril-valsartan to treat HFrEF had similar total health care spending as those initiating ACE-I/ARBs; higher prescription drug spending was offset by lower inpatient and outpatient spending. However, sacubitril-valsartan use was associated with higher patient out-of-pocket costs, which may exacerbate health disparities and limit access and affordability
Internal Medicine (2 works) · Medication Adherence and Compliance (2 works) · Medicine (2 works) · Blood pressure (1 works) · Cardiac pacing and defibrillation studies (1 works) · Cardiology (1 works) · Cohort study (1 works) · Confidence interval (1 works) · Diabetes Management and Education (1 works) · Ejection fraction (1 works)